EquityFlow
›
Companies
› Surge
Surge
Biotech
· Paris, FR
High-dimensional immune-system analysis for precision medicine.
Funding history
Date
Round
Amount
Mar 2024
Funding round
Surge, a Paris immune-system-analysis biotech, raised EUR7.5M led by Eurazeo.
$8.1M
Investors
Eurazeo
Kima
Teampact
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →